📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

MutY-Homolog (MYH) inhibition reduces pancreatic cancer cell growth and increases chemosensitivity. (2017)

First Author: Sharbeen G

Attributed to: The Scottish Genomes Partnership funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.18632/oncotarget.13985

PubMed Identifier: 27999205

Publication URI: http://europepmc.org/abstract/MED/27999205

Type: Journal Article/Review

Volume: 8

Parent Publication: Oncotarget

Issue: 6

ISSN: 1949-2553